Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial for Randomized Controlled Trial Patients with Metastatic Spine Disease.
Gardner UG Jr, Brately MM, Zuhour RJ, Sun Y, Spratt DE, McClelland S 3rd. Gardner UG Jr, et al. Among authors: spratt de. Rep Pract Oncol Radiother. 2024 Dec 4;29(5):657-660. doi: 10.5603/rpor.102822. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39759561 Free PMC article.
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Bryce AH, Agarwal N, Beltran H, Hussain MH, Sartor O, Shore N, Antonarakis ES, Armstrong AJ, Calais J, Carducci MA, Dorff TB, Efstathiou JA, Gleave M, Gomella LG, Higano C, Hope TA, Iagaru A, Morgans AK, Morris DS, Morris MJ, Petrylak DP, Reiter RE, Rettig MB, Ryan CJ, Sellinger SB, Spratt DE, Srinivas S, Tagawa ST, Taplin ME, Yu EY, Zhang T, McKay RR, Koo PJ, Crawford ED. Bryce AH, et al. Among authors: spratt de. Cancer. 2025 Jan 1;131(1):e35612. doi: 10.1002/cncr.35612. Epub 2024 Dec 1. Cancer. 2025. PMID: 39616467 Free PMC article.
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Patel KR, Nguyen PL, Proudfoot JA, Liu Y, Pra AD, Spratt DE, Pollack A, Sandler HM, Efstathiou JA, Lawton C, Simko JP, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Pugh SL, Davicioni E, Tran PT, Feng FY. Patel KR, et al. Among authors: spratt de. Eur Urol Oncol. 2024 Nov 13:S2588-9311(24)00246-3. doi: 10.1016/j.euo.2024.10.017. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39542826
Response to simprini and Osazuwa-Peters.
Mani KA, Wu X, Spratt DE, Wang M, Zaorsky NG. Mani KA, et al. Among authors: spratt de. J Natl Cancer Inst. 2024 Nov 14:djae290. doi: 10.1093/jnci/djae290. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39540808 No abstract available.
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Tward JD, Huang HC, Esteva A, Mohamad O, van der Wal D, Simko JP, DeVries S, Zhang J, Joun S, Showalter TN, Schaeffer EM, Morgan TM, Monson JM, Wallace JA, Bahary JP, Sandler HM, Spratt DE, Rodgers JP, Feng FY, Tran PT. Tward JD, et al. Among authors: spratt de. JCO Precis Oncol. 2024 Oct;8:e2400145. doi: 10.1200/PO.24.00145. Epub 2024 Oct 24. JCO Precis Oncol. 2024. PMID: 39447096 Free PMC article. Clinical Trial.
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
Patel SA, Patil D, Smith J, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Michalski JM, Wood DP, Hembroff LA, Spratt DE, Wei JT, Sandler HM, Hamstra DA, Pisters L, Kuban D, Regan MM, Wagner A, Crociani CM, Kaplan I, Sanda MG, Chang P; PROST-QA/RP2 Consortium. Patel SA, et al. Among authors: spratt de. JAMA Netw Open. 2024 Oct 1;7(10):e2440747. doi: 10.1001/jamanetworkopen.2024.40747. JAMA Netw Open. 2024. PMID: 39446326 Free PMC article.
503 results